When and how should the patients with dermatomyositis be assessed for interstitial lung disease？  

作　　者：GUO Li-shao ZHANG Jian-zhong 

机构地区：[1]Chinese Medical Journal, Chinese Medical Association, Beijing 100710, China [2]Department of Dermatology, Peking University People's Hospital, Beijing 100044, China

出　　处：《Chinese Medical Journal》2010年第5期515-516,共2页中华医学杂志（英文版）

摘　　要：Dermatomyositis （DM） and polymyositis （PM） are idiopathic inflammatory myopathies with unknown etiology. The incidence of both diseases is estimated at 4 to 10 cases per million people per year.1 Classical DM patients display characteristic cutaneous manifestations, proximal muscle weakness, and laboratorial evidence of myositis. Skin manifestations include the classic periorbital heliotrope,Dermatomyositis （DM） and polymyositis （PM） are idiopathic inflammatory myopathies with unknown etiology. The incidence of both diseases is estimated at 4 to 10 cases per million people per year.1 Classical DM patients display characteristic cutaneous manifestations, proximal muscle weakness, and laboratorial evidence of myositis. Skin manifestations include the classic periorbital heliotrope,

分 类 号：S858.237.1[农业科学—临床兽医学] TN946.7[农业科学—兽医学]